Grant: Discovery Grants Program - Individual
University of Calgary
$64,000.00
Biased Agonism Mediated by the Glucocorticoid Receptor
EF 2022-23
Résumé
BackgroundGlucocorticoids are a family of naturally-occurring and synthetic agonists, which regulate the expression of genes controlling a wide variety of physiological functions including metabolism, development, inflammation and the immune system. These genomic effects are mediated by the glucocorticoid receptor (GR), a ligand-activated transcription factor, which is a member of the nuclear hormone receptor (NHR) superfamily.Current concepts of GR-mediated gene expression assume that GR adopts the same, static conformation when bound by an activating ligand (i.e. agonist). Accordingly, the magnitude of gene expression changes is governed by the transcriptional competency of the ligand-receptor complex, which is determined by the innate chemical structure of the agonist. However, structural biologists have unequivocally established that GR can adopt multiple, interchangeable conformations, which are differentially stabilized in an agonist-dependent manner. Borrowing from the literature on 7-transmembrane spanning receptors, this plasticity may allow GR to interact, preferentially, with one gene promoter (or population of promoters) over another leading to distinct, agonist-directed programs of gene expression by a process called biased agonism.HypothesisThe overall hypothesis is that distinct programs of GR-mediated gene expression can be generated in a given cell type that depend on the innate structure of an activating ligand and its ability to create unique conformations of GR. This changes the complement and stoichiometry of obligatory co-factors that bind to GR and, thereby, its ability to interact productively at certain gene promoters over others.Aims To conduct a "proof-of-concept" study to establish GR-mediated gene expression bias; To validate, quantify and analyse, using bioinformatics approaches, gene expression bias; To explore in vitro the biological activity of biased GR agonists.Anticipated Outcomes and Discovery PotentialThis programme of research will apply biological, analytical and bioinformatics approaches, to establish a fundamental biological process of GR-mediated gene expression whereby distinct, transcriptional signatures are directed by the innate structure of an activating ligand. Many ligands have been identified with the potential to stabilise GR in distinct conformations and direct different patterns of gene expression through biased agonism. A ligand, by creating a unique, GR conformer, should be able to "program" a cell to preferentially express distinct populations of genes with attendant functional consequences. Establishing the principle of GR-mediated, biased agonism could be extrapolated to other NHRs, apply across species and be relevant to all biologists interested in the regulation of gene expression.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2018-04312
Name nom
Giembycz, Mark
Department département
Physiology and Pharmacology - Physiology and Pharmacology
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2018
Award amount
64000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Installment
inst:5;6
Partie
2
Nb partie
6
Application title
Biased Agonism Mediated by the Glucocorticoid Receptor
Application summary
BackgroundGlucocorticoids are a family of naturally-occurring and synthetic agonists, which regulate the expression of genes controlling a wide variety of physiological functions including metabolism, development, inflammation and the immune system. These genomic effects are mediated by the glucocorticoid receptor (GR), a ligand-activated transcription factor, which is a member of the nuclear hormone receptor (NHR) superfamily.Current concepts of GR-mediated gene expression assume that GR adopts the same, static conformation when bound by an activating ligand (i.e. agonist). Accordingly, the magnitude of gene expression changes is governed by the transcriptional competency of the ligand-receptor complex, which is determined by the innate chemical structure of the agonist. However, structural biologists have unequivocally established that GR can adopt multiple, interchangeable conformations, which are differentially stabilized in an agonist-dependent manner. Borrowing from the literature on 7-transmembrane spanning receptors, this plasticity may allow GR to interact, preferentially, with one gene promoter (or population of promoters) over another leading to distinct, agonist-directed programs of gene expression by a process called biased agonism.HypothesisThe overall hypothesis is that distinct programs of GR-mediated gene expression can be generated in a given cell type that depend on the innate structure of an activating ligand and its ability to create unique conformations of GR. This changes the complement and stoichiometry of obligatory co-factors that bind to GR and, thereby, its ability to interact productively at certain gene promoters over others.Aims To conduct a "proof-of-concept" study to establish GR-mediated gene expression bias; To validate, quantify and analyse, using bioinformatics approaches, gene expression bias; To explore in vitro the biological activity of biased GR agonists.Anticipated Outcomes and Discovery PotentialThis programme of research will apply biological, analytical and bioinformatics approaches, to establish a fundamental biological process of GR-mediated gene expression whereby distinct, transcriptional signatures are directed by the innate structure of an activating ligand. Many ligands have been identified with the potential to stabilise GR in distinct conformations and direct different patterns of gene expression through biased agonism. A ligand, by creating a unique, GR conformer, should be able to "program" a cell to preferentially express distinct populations of genes with attendant functional consequences. Establishing the principle of GR-mediated, biased agonism could be extrapolated to other NHRs, apply across species and be relevant to all biologists interested in the regulation of gene expression.